Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |